91 related articles for article (PubMed ID: 8645031)
21. [A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
Shimada K; Karaki Y; Ansai Y; Hino K; Yamashita Y; Fujimaki M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):623-6. PubMed ID: 8678522
[TBL] [Abstract][Full Text] [Related]
22. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.
Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH
Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
[TBL] [Abstract][Full Text] [Related]
24. [Bone-related events in breast cancer].
Kurebayashi J
Clin Calcium; 2008 Apr; 18(4):447-54. PubMed ID: 18379025
[TBL] [Abstract][Full Text] [Related]
25. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy].
Itoshima T; Yamamoto T; Kasamatsu T; Fujino H; Yamamoto H; Morita Y; Kodama M
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355
[TBL] [Abstract][Full Text] [Related]
26. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
[TBL] [Abstract][Full Text] [Related]
27. LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen.
Berlière M; Galant C; Marques G; Piette P; Duck L; Fellah L; Donnez J; Machiels JP
Eur J Cancer; 2004 Aug; 40(12):1855-61. PubMed ID: 15288287
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant therapy during the administration of GnRH agonists].
Nikolov A; Kolarov G
Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
[No Abstract] [Full Text] [Related]
29. [New period of systemic treatment for breast cancer].
Hamaoka T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1457-60. PubMed ID: 18799897
[TBL] [Abstract][Full Text] [Related]
30. Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
Neoplasma; 1997; 44(5):308-13. PubMed ID: 9473791
[TBL] [Abstract][Full Text] [Related]
31. Aromatase inhibitor withdrawal response in metastatic breast cancer.
Cigler T; Goss PE
J Clin Oncol; 2006 Apr; 24(12):1955-6. PubMed ID: 16622274
[No Abstract] [Full Text] [Related]
32. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432
[TBL] [Abstract][Full Text] [Related]
33. [Endocrine therapy for prostate cancer in the future].
Usami M
Gan To Kagaku Ryoho; 1998 May; 25(6):817-22. PubMed ID: 9617319
[TBL] [Abstract][Full Text] [Related]
34. A case of premenopausal breast cancer showing remarkable elevation of serum alkaline phosphatase level during treatment with LH-RH analog.
Ito K; Komatsu A; Kanai T; Koyama H; Hama Y; Shingu K; Fujimori M; Amano J
Breast J; 2005; 11(6):523-4. PubMed ID: 16297128
[No Abstract] [Full Text] [Related]
35. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
von Minckwitz G; Graf E; Geberth M; Eiermann W; Jonat W; Conrad B; Brunnert K; Gerber B; Vescia S; Wollert J; Kaufmann M
Eur J Cancer; 2006 Aug; 42(12):1780-8. PubMed ID: 16765589
[TBL] [Abstract][Full Text] [Related]
36. Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis.
Glück S
Can J Oncol; 1995 Dec; 5 Suppl 1():58-62. PubMed ID: 8853527
[TBL] [Abstract][Full Text] [Related]
37. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
38. Treatment of an orchiectomized patient with hormone-refractory prostate cancer with LH-RH agonists.
Damyanov C; Tzingilev B; Tabakov V
Eur Urol; 2001 Oct; 40(4):474-6; discussion 477. PubMed ID: 11713406
[TBL] [Abstract][Full Text] [Related]
39. [Breast cancer].
Iwase H
Nihon Rinsho; 2006 Sep; Suppl 3():379-83. PubMed ID: 17022569
[No Abstract] [Full Text] [Related]
40. Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer.
Matsumoto M; Miyauchi M; Yamamoto N; Shishikura T; Imanaka N
Breast Cancer; 2000; 7(3):237-40. PubMed ID: 11029804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
